Confirmatory Phase 3 trial of roluperidone for negative symptoms of schizophrenia initiated and first patient screenedPrevious open label trial ...
Confirmatory Phase 3 trial of roluperidone for negative symptoms of schizophrenia initiated and first patient screened Previous open label trial data presented at SIRS 2026 showed no safety or drug-dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results